Viruses are simple in structure: They consist of a small amount of genetic material wrapped in proteins and lipids. Measuring just 20 to 200 nanometers in size, they can only be detected with an electron microscope. Yet their ...
Jun 1, 2022
0
18
Researchers at Mayo Clinic's Center for Individualized Medicine have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively ...
Apr 13, 2022
0
94
With the world still in the grip of a devastating pandemic, it's hard to imagine viruses as something other than hostile enemies to be vanquished.
Nov 30, 2021
0
6
A novel therapy engineered by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, according to results from a recent phase I clinical trial ...
Jul 30, 2021
0
79
Researchers from the Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the LIH Department of Oncology (DONC) are working on the development of novel anticancer strategies based on oncolytic viruses, 'good' viruses ...
Jun 29, 2021
0
22
In her laboratory at the University of Montreal Hospital Research Centre (CRCHUM), Marie-Claude Bourgeois-Daigneault and a team of scientists usually modify viruses to make them specific to the cells of a tumor.
May 11, 2021
0
6
Researchers from Queen Mary University of London and Zhengzhou University have developed a powerful therapeutic platform that uses a modified virus for the treatment of pancreatic cancer. By using the virus in combination ...
Jan 27, 2021
0
45
Combining a gene-targeted drug, a cancer-bursting virus and a drug that removes the immune system's brake pedal can tackle thyroid cancer with newfound gusto, research has found.
Dec 8, 2020
0
19
Many cancer researchers can claim to have devised "smart bombs." What has been missing is the stealth bomber—a delivery system that can slip through the body's radar defenses.
Nov 25, 2020
1
101
City of Hope scientists have combined two potent immunotherapies—an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy—to target and eradicate solid tumors that are otherwise difficult to treat with CAR ...
Sep 2, 2020
1
118
